Diagnostics and treatment of tumor-lysis syndrome during chemotherapy of non-Hodgkin’s lymphoma

Avierin, D. and Artemenko, M. and Kashchenko, O. (2019) Diagnostics and treatment of tumor-lysis syndrome during chemotherapy of non-Hodgkin’s lymphoma. Онкологія=Онкология=Oncology, Т. 21 (№ 1). p. 94. ISSN 1562-1774 (Print), 2663-7928 (Online)

[img]
Preview
Text
X МІЖНАРОДНИЙ СЕМІНАР СТУДЕНТІВ ТА МОЛОДИХ ВЧЕНИХ_2019 Київ_С.94.pdf

Download (558kB) | Preview
Official URL: http://www.oncology.kiev.ua/

Abstract

Tumor lysis syndrome (TLS) is one of the most dangerous and serious emergency conditions in oncological practice, especially in pediatric oncology. It is characterized by acute and massive lysis of tumor cells during chemotherapy (CT), which leads to serious hematological and organ disorders in a short time. Aim: to define risk factors of developing the TLS, to form risk groups depending on the primary disease, to identify symptoms of a group of risk factors. Materials and methods. 120 cases of clinical TLS development in the CT department of Dnipro State Multi-Field Clinical Hospital № 4 were selected and analyzed. Straight and sideway signs of the development of clinical TLS were identified, the effectiveness of allopurinol and acetazolamide in the systemic treatment of TLS was estimated.

Item Type: Article
Additional Information: X Міжнародний семінар студентів та молодих вчених, присвячений Всесвітньому дню боротьби з раком. Київ, Україна, 31 січня–1 лютого 2019 р.
Subjects: Oncology
Divisions: Departments > Department of Oncology and Medical Radiology
Depositing User: Елена Шрамко
Date Deposited: 14 May 2020 09:42
Last Modified: 14 May 2020 10:41
URI: http://repo.dma.dp.ua/id/eprint/5346

Actions (login required)

View Item View Item